Publications
579 found
Show per page
Mondesert, E., Delaby, C., De La Cruz, E., Kuhle, J., Benkert, P., Pradeilles, N., Duchiron, M., Morchikh, M., Camu, W., Cristol, J.-P., Hirtz, C., Esselin, F., & Lehmann, S. (2025). Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis [Journal-article]. Neurology, 104(6). https://doi.org/10.1212/wnl.0000000000213400
Mondesert, E., Delaby, C., De La Cruz, E., Kuhle, J., Benkert, P., Pradeilles, N., Duchiron, M., Morchikh, M., Camu, W., Cristol, J.-P., Hirtz, C., Esselin, F., & Lehmann, S. (2025). Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis [Journal-article]. Neurology, 104(6). https://doi.org/10.1212/wnl.0000000000213400
Oechtering, Johanna, Schaedelin, Sabine Anna, Stein, Kerstin, Maceski, Aleksandra Maleska, Melie-Garcia, Lester, Benkert, Pascal, Cagol, Alessandro, Leber, Selina, Galbusera, Riccardo, Ruberte, Esther, Hu, Wayne, Qureshi, Ferhan, Orleth, Annette, Demuth, Lilian, Willemse, Eline, Heijnen, Ingmar, Regeniter, Axel, Derfuss, Tobias J., Fischer-Barnicol, Bettina, et al. (2025). Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis. Neurology: Neuroimmunology and NeuroInflammation, 12. https://doi.org/10.1212/NXI.0000000000200361
Oechtering, Johanna, Schaedelin, Sabine Anna, Stein, Kerstin, Maceski, Aleksandra Maleska, Melie-Garcia, Lester, Benkert, Pascal, Cagol, Alessandro, Leber, Selina, Galbusera, Riccardo, Ruberte, Esther, Hu, Wayne, Qureshi, Ferhan, Orleth, Annette, Demuth, Lilian, Willemse, Eline, Heijnen, Ingmar, Regeniter, Axel, Derfuss, Tobias J., Fischer-Barnicol, Bettina, et al. (2025). Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis. Neurology: Neuroimmunology and NeuroInflammation, 12. https://doi.org/10.1212/NXI.0000000000200361
Barakovic, Muhamed, Weigel, Matthias, Cagol, Alessandro, Schaedelin, Sabine, Galbusera, Riccardo, Lu, Po-Jui, Chen, Xinjie, Melie-Garcia, Lester, Ocampo-Pineda, Mario, Bahn, Erik, Stadelmann, Christine, Palombo, Marco, Kappos, Ludwig, Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-60497-6
, Magon, Stefano, & Granziera, Cristina. (2024). A novel imaging marker of cortical “cellularity” in multiple sclerosis patients [Journal-article].
Barakovic, Muhamed, Weigel, Matthias, Cagol, Alessandro, Schaedelin, Sabine, Galbusera, Riccardo, Lu, Po-Jui, Chen, Xinjie, Melie-Garcia, Lester, Ocampo-Pineda, Mario, Bahn, Erik, Stadelmann, Christine, Palombo, Marco, Kappos, Ludwig, Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-60497-6
, Magon, Stefano, & Granziera, Cristina. (2024). A novel imaging marker of cortical “cellularity” in multiple sclerosis patients [Journal-article].
Janiaud, Perrine, Zecca, Chiara, Salmen, Anke, Benkert, Pascal, Schädelin, Sabine, Orleth, Annette, Demuth, Lilian, Maceski, Aleksandra Maleska, Granziera, Cristina, Oechtering, Johanna, Leppert, David, Derfuss, Tobias, Achtnichts, Lutz, Findling, Oliver, Roth, Patrick, Lalive, Patrice, Uginet, Marjolaine, Müller, Stefanie, Pot, Caroline, et al. (2024). MultiSCRIPT-Cycle 1—a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial. Trials, 25(1). https://doi.org/10.1186/s13063-024-08454-6
Janiaud, Perrine, Zecca, Chiara, Salmen, Anke, Benkert, Pascal, Schädelin, Sabine, Orleth, Annette, Demuth, Lilian, Maceski, Aleksandra Maleska, Granziera, Cristina, Oechtering, Johanna, Leppert, David, Derfuss, Tobias, Achtnichts, Lutz, Findling, Oliver, Roth, Patrick, Lalive, Patrice, Uginet, Marjolaine, Müller, Stefanie, Pot, Caroline, et al. (2024). MultiSCRIPT-Cycle 1—a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial. Trials, 25(1). https://doi.org/10.1186/s13063-024-08454-6
Sehr, Tony, Akgün, Katja, Benkert, Pascal, Journal of Sleep Research, 33(5). https://doi.org/10.1111/jsr.14164
, Ziemssen, Tjalf, & Brandt, Moritz D. (2024). Effects of obstructive sleep apnea treatment on neurodegenerative biomarker neurofilament light chain and cognitive performance.
Sehr, Tony, Akgün, Katja, Benkert, Pascal, Journal of Sleep Research, 33(5). https://doi.org/10.1111/jsr.14164
, Ziemssen, Tjalf, & Brandt, Moritz D. (2024). Effects of obstructive sleep apnea treatment on neurodegenerative biomarker neurofilament light chain and cognitive performance.
Cagol, Alessandro, Ocampo-Pineda, Mario, Lu, Po-Jui, Weigel, Matthias, Barakovic, Muhamed, Melie-Garcia, Lester, Chen, Xinjie, Lutti, Antoine, Calabrese, Pasquale, Neurology: Neuroimmunology and NeuroInflammation, 11(6). https://doi.org/10.1212/NXI.0000000000200299
, Kappos, Ludwig, Sormani, Maria Pia, & Granziera, Cristina. (2024). Advanced Quantitative MRI Unveils Microstructural Thalamic Changes Reflecting Disease Progression in Multiple Sclerosis [Journal-article].
Cagol, Alessandro, Ocampo-Pineda, Mario, Lu, Po-Jui, Weigel, Matthias, Barakovic, Muhamed, Melie-Garcia, Lester, Chen, Xinjie, Lutti, Antoine, Calabrese, Pasquale, Neurology: Neuroimmunology and NeuroInflammation, 11(6). https://doi.org/10.1212/NXI.0000000000200299
, Kappos, Ludwig, Sormani, Maria Pia, & Granziera, Cristina. (2024). Advanced Quantitative MRI Unveils Microstructural Thalamic Changes Reflecting Disease Progression in Multiple Sclerosis [Journal-article].
Linnemann, Christoph, Wilke, Carlo, Mengel, David, Zetterberg, Henrik, Heller, Carolin, Journal of Neurology, Neurosurgery and Psychiatry, 95(9), 822–828. https://doi.org/10.1136/jnnp-2023-332464
, Bouzigues, Arabella, Russell, Lucy L, Foster, Phoebe H, Ferry-Bolder, Eve, Van Swieten, John Cornelis, Jiskoot, Lize C, Seelaar, Harro, Moreno, Fermin, Borroni, Barbara, Sánchez-Valle, Raquel, Galimberti, Daniela, Laforce, Robert, Graff, Caroline, et al. (2024). NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: A large GENFI study [Journal-article].
Linnemann, Christoph, Wilke, Carlo, Mengel, David, Zetterberg, Henrik, Heller, Carolin, Journal of Neurology, Neurosurgery and Psychiatry, 95(9), 822–828. https://doi.org/10.1136/jnnp-2023-332464
, Bouzigues, Arabella, Russell, Lucy L, Foster, Phoebe H, Ferry-Bolder, Eve, Van Swieten, John Cornelis, Jiskoot, Lize C, Seelaar, Harro, Moreno, Fermin, Borroni, Barbara, Sánchez-Valle, Raquel, Galimberti, Daniela, Laforce, Robert, Graff, Caroline, et al. (2024). NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: A large GENFI study [Journal-article].
Linnemann, Christoph, Wilke, Carlo, Mengel, David, Zetterberg, Henrik, Heller, Carolin, Journal of Neurology, Neurosurgery and Psychiatry, 95(9), 822–828. https://doi.org/10.1136/jnnp-2023-332464
, Bouzigues, Arabella, Russell, Lucy L., Foster, Phoebe H., Ferry-Bolder, Eve, Van Swieten, John Cornelis, Jiskoot, Lize C., Seelaar, Harro, Moreno, Fermin, Borroni, Barbara, Sánchez-Valle, Raquel, Galimberti, Daniela, Laforce, Robert Jr, Graff, Caroline, et al. (2024). NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: A large GENFI study.
Linnemann, Christoph, Wilke, Carlo, Mengel, David, Zetterberg, Henrik, Heller, Carolin, Journal of Neurology, Neurosurgery and Psychiatry, 95(9), 822–828. https://doi.org/10.1136/jnnp-2023-332464
, Bouzigues, Arabella, Russell, Lucy L., Foster, Phoebe H., Ferry-Bolder, Eve, Van Swieten, John Cornelis, Jiskoot, Lize C., Seelaar, Harro, Moreno, Fermin, Borroni, Barbara, Sánchez-Valle, Raquel, Galimberti, Daniela, Laforce, Robert Jr, Graff, Caroline, et al. (2024). NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: A large GENFI study.
Roos, I., Sharmin, S., Malpas, C., Ozakbas, S., Lechner-Scott, J., Hodgkinson, S., Alroughani, R., Eichau Madueño, S., Boz, C., van der Walt, A., Butzkueven, H., Buzzard, K., Skibina, O., Foschi, M., Grand’Maison, F., John, N., Grammond, P., Terzi, M., Prévost, J., et al. (2024). Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 30(9), 1163–1175. https://doi.org/10.1177/13524585241267211
Roos, I., Sharmin, S., Malpas, C., Ozakbas, S., Lechner-Scott, J., Hodgkinson, S., Alroughani, R., Eichau Madueño, S., Boz, C., van der Walt, A., Butzkueven, H., Buzzard, K., Skibina, O., Foschi, M., Grand’Maison, F., John, N., Grammond, P., Terzi, M., Prévost, J., et al. (2024). Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 30(9), 1163–1175. https://doi.org/10.1177/13524585241267211
Schindler, P., Bellmann-Strobl, J., Kuhle, J., Wildemann, B., Jarius, S., Paul, F., & Ruprecht, K. (2024). Longitudinal change of serum NfL as disease activity biomarker candidate in MOGAD: A descriptive cohort study. Multiple Sclerosis and Related Disorders, 88. https://doi.org/10.1016/j.msard.2024.105729
Schindler, P., Bellmann-Strobl, J., Kuhle, J., Wildemann, B., Jarius, S., Paul, F., & Ruprecht, K. (2024). Longitudinal change of serum NfL as disease activity biomarker candidate in MOGAD: A descriptive cohort study. Multiple Sclerosis and Related Disorders, 88. https://doi.org/10.1016/j.msard.2024.105729
Zivadinov, R., Jakimovski, D., Burnham, A., Kuhle, J., Weinstock, Z., Wicks, T. R., Ramanathan, M., Sciortino, T., Ostrem, M., Suchan, C., Dwyer, M. G., Reilly, J., Bergsland, N., Schweser, F., Kennedy, C., Young-Hong, D., Eckert, S., Hojnacki, D., Benedict, R. H. B., & Weinstock-Guttman, B. (2024). Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA–MS case-controlled study. Journal of Neurology, 271(8), 4949–4962. https://doi.org/10.1007/s00415-024-12420-2
Zivadinov, R., Jakimovski, D., Burnham, A., Kuhle, J., Weinstock, Z., Wicks, T. R., Ramanathan, M., Sciortino, T., Ostrem, M., Suchan, C., Dwyer, M. G., Reilly, J., Bergsland, N., Schweser, F., Kennedy, C., Young-Hong, D., Eckert, S., Hojnacki, D., Benedict, R. H. B., & Weinstock-Guttman, B. (2024). Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA–MS case-controlled study. Journal of Neurology, 271(8), 4949–4962. https://doi.org/10.1007/s00415-024-12420-2
Chalkou, Konstantina, Hamza, Tasnim, Benkert, Pascal, Research Synthesis Methods, 15(4), 641–656. https://doi.org/10.1002/jrsm.1717
, Zecca, Chiara, Simoneau, Gabrielle, Pellegrini, Fabio, Manca, Andrea, Egger, Matthias, & Salanti, Georgia. (2024). Combining randomized and non-randomized data to predict heterogeneous effects of competing treatments.
Chalkou, Konstantina, Hamza, Tasnim, Benkert, Pascal, Research Synthesis Methods, 15(4), 641–656. https://doi.org/10.1002/jrsm.1717
, Zecca, Chiara, Simoneau, Gabrielle, Pellegrini, Fabio, Manca, Andrea, Egger, Matthias, & Salanti, Georgia. (2024). Combining randomized and non-randomized data to predict heterogeneous effects of competing treatments.
Zuo, Michelle, Fettig, Naomi M., Bernier, Louis-Philippe, Pössnecker, Elisabeth, Spring, Shoshana, Pu, Annie, Ma, Xianjie I., Lee, Dennis Sw, Ward, Lesley A., Sharma, Anshu, JCI Insight, 9(12). https://doi.org/10.1172/jci.insight.183445
, Sled, John G., Pröbstel, Anne-Katrin, MacVicar, Brian A., Osborne, Lisa C., Gommerman, Jennifer L., & Ramaglia, Valeria. (2024). Erratum: Age-dependent gray matter demyelination is associated with leptomeningeal neutrophil accumulation (JCI insight PII: e183445).
Zuo, Michelle, Fettig, Naomi M., Bernier, Louis-Philippe, Pössnecker, Elisabeth, Spring, Shoshana, Pu, Annie, Ma, Xianjie I., Lee, Dennis Sw, Ward, Lesley A., Sharma, Anshu, JCI Insight, 9(12). https://doi.org/10.1172/jci.insight.183445
, Sled, John G., Pröbstel, Anne-Katrin, MacVicar, Brian A., Osborne, Lisa C., Gommerman, Jennifer L., & Ramaglia, Valeria. (2024). Erratum: Age-dependent gray matter demyelination is associated with leptomeningeal neutrophil accumulation (JCI insight PII: e183445).
Signori, Alessio, Ponzano, Marta, Kalincik, Tomas, Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva Kubala, Alroughani, Raed, Patti, Francesco, Journal of Neurology, Neurosurgery and Psychiatry, 95(7), 620–625. https://doi.org/10.1136/jnnp-2023-332603
, Izquierdo, Guillermo, Eichau, Sara, Yamout, Bassem, Khoury, Samia Joseph, Karabudak, Rana, Grammond, Pierre, Duquette, Pierre, Roos, Izanne, Butzkueven, Helmut, van der Walt, Anneke, & Sormani, Maria Pia. (2024). Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: An application using data from the MSBase Registry.
Signori, Alessio, Ponzano, Marta, Kalincik, Tomas, Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva Kubala, Alroughani, Raed, Patti, Francesco, Journal of Neurology, Neurosurgery and Psychiatry, 95(7), 620–625. https://doi.org/10.1136/jnnp-2023-332603
, Izquierdo, Guillermo, Eichau, Sara, Yamout, Bassem, Khoury, Samia Joseph, Karabudak, Rana, Grammond, Pierre, Duquette, Pierre, Roos, Izanne, Butzkueven, Helmut, van der Walt, Anneke, & Sormani, Maria Pia. (2024). Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: An application using data from the MSBase Registry.
Fischbach, F., Richter, J., Pfeffer, L. K., Fehse, B., Berger, S. C., Reinhardt, S., Kuhle, J., Badbaran, A., Rathje, K., Gagelmann, N., Borie, D., Seibel, J., Ayuk, F., Friese, M. A., Heesen, C., & Kröger, N. (2024). CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis. Med, 5(6), 550–558. https://doi.org/10.1016/j.medj.2024.03.002
Fischbach, F., Richter, J., Pfeffer, L. K., Fehse, B., Berger, S. C., Reinhardt, S., Kuhle, J., Badbaran, A., Rathje, K., Gagelmann, N., Borie, D., Seibel, J., Ayuk, F., Friese, M. A., Heesen, C., & Kröger, N. (2024). CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis. Med, 5(6), 550–558. https://doi.org/10.1016/j.medj.2024.03.002
Hirt, Julian, Dembowska, Kinga, Woelfle, Tim, Axfors, Cathrine, Granziera, Cristina, Journal of Neurology, 271(6), 3131–3141. https://doi.org/10.1007/s00415-024-12366-5
, Kappos, Ludwig, Hemkens, Lars G., & Janiaud, Perrine. (2024). Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis.
Hirt, Julian, Dembowska, Kinga, Woelfle, Tim, Axfors, Cathrine, Granziera, Cristina, Journal of Neurology, 271(6), 3131–3141. https://doi.org/10.1007/s00415-024-12366-5
, Kappos, Ludwig, Hemkens, Lars G., & Janiaud, Perrine. (2024). Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis.
Maatta, L. L., Andersen, S. T., Parkner, T., Hviid, C. V. B., Bjerg, L., Kural, M. A., Charles, M., Søndergaard, E., Kuhle, J., Tankisi, H., Witte, D. R., & Jensen, T. S. (2024). Longitudinal Change in Serum Neurofilament Light Chain in Type 2 Diabetes and Early Diabetic Polyneuropathy: ADDITION-Denmark. Diabetes Care, 47(6), 986–994. https://doi.org/10.2337/dc23-2208
Maatta, L. L., Andersen, S. T., Parkner, T., Hviid, C. V. B., Bjerg, L., Kural, M. A., Charles, M., Søndergaard, E., Kuhle, J., Tankisi, H., Witte, D. R., & Jensen, T. S. (2024). Longitudinal Change in Serum Neurofilament Light Chain in Type 2 Diabetes and Early Diabetic Polyneuropathy: ADDITION-Denmark. Diabetes Care, 47(6), 986–994. https://doi.org/10.2337/dc23-2208
Fissolo, Nicolás, Benkert, Pascal, Sastre-Garriga, Jaume, Mongay-Ochoa, Neus, Vilaseca-Jolonch, Andreu, Llufriu, Sara, Blanco, Yolanda, Hegen, Harald, Berek, Klaus, Perez-Miralles, Francisco, Rejdak, Konrad, Villar, Luisa M., Monreal, Enric, Alvarez-Lafuente, Roberto, Soylu, Onder K., Abdelhak, Ahmed, Bachhuber, Franziska, Tumani, Hayrettin, Martínez-Yélamos, Sergio, et al. (2024). Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 95(5), 410–418. https://doi.org/10.1136/jnnp-2023-332251
Fissolo, Nicolás, Benkert, Pascal, Sastre-Garriga, Jaume, Mongay-Ochoa, Neus, Vilaseca-Jolonch, Andreu, Llufriu, Sara, Blanco, Yolanda, Hegen, Harald, Berek, Klaus, Perez-Miralles, Francisco, Rejdak, Konrad, Villar, Luisa M., Monreal, Enric, Alvarez-Lafuente, Roberto, Soylu, Onder K., Abdelhak, Ahmed, Bachhuber, Franziska, Tumani, Hayrettin, Martínez-Yélamos, Sergio, et al. (2024). Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 95(5), 410–418. https://doi.org/10.1136/jnnp-2023-332251
Khalil, Michael, Teunissen, Charlotte E., Lehmann, Sylvain, Otto, Markus, Piehl, Fredrik, Ziemssen, Tjalf, Bittner, Stefan, Sormani, Maria Pia, Gattringer, Thomas, Abu-Rumeileh, Samir, Thebault, Simon, Abdelhak, Ahmed, Green, Ari, Benkert, Pascal, Kappos, Ludwig, Comabella, Manuel, Tumani, Hayrettin, Freedman, Mark S., Petzold, Axel, et al. (2024). Neurofilaments as biomarkers in neurological disorders — towards clinical application. Nature Reviews Neurology, 20(5), 269–287. https://doi.org/10.1038/s41582-024-00955-x
Khalil, Michael, Teunissen, Charlotte E., Lehmann, Sylvain, Otto, Markus, Piehl, Fredrik, Ziemssen, Tjalf, Bittner, Stefan, Sormani, Maria Pia, Gattringer, Thomas, Abu-Rumeileh, Samir, Thebault, Simon, Abdelhak, Ahmed, Green, Ari, Benkert, Pascal, Kappos, Ludwig, Comabella, Manuel, Tumani, Hayrettin, Freedman, Mark S., Petzold, Axel, et al. (2024). Neurofilaments as biomarkers in neurological disorders — towards clinical application. Nature Reviews Neurology, 20(5), 269–287. https://doi.org/10.1038/s41582-024-00955-x
Müller, Jannis, Roos, Izanne, Kalincik, Tomas, Lorscheider, Johannes, Galli, Edoardo, Benkert, Pascal, Schädelin, Sabine, Sharmin, Sifat, Einsiedler, Maximilian, Hänni, Peter, Schmid, Jürg, Brain and Behavior, 14(5). https://doi.org/10.1002/brb3.3498
, Derfuss, Tobias, Granziera, Cristina, Ziemssen, Tjalf, Siepmann, Timo, & Yaldizli, Özgür. (2024). Escalating to medium- versus high-efficacy disease modifying therapy after low-efficacy treatment in relapsing remitting multiple sclerosis.
Müller, Jannis, Roos, Izanne, Kalincik, Tomas, Lorscheider, Johannes, Galli, Edoardo, Benkert, Pascal, Schädelin, Sabine, Sharmin, Sifat, Einsiedler, Maximilian, Hänni, Peter, Schmid, Jürg, Brain and Behavior, 14(5). https://doi.org/10.1002/brb3.3498
, Derfuss, Tobias, Granziera, Cristina, Ziemssen, Tjalf, Siepmann, Timo, & Yaldizli, Özgür. (2024). Escalating to medium- versus high-efficacy disease modifying therapy after low-efficacy treatment in relapsing remitting multiple sclerosis.
Sharmin, S., Roos, I., Malpas, C. B., Iaffaldano, P., Simone, M., Filippi, M., Kubala Havrdova, E., Ozakbas, S., Brescia Morra, V., Alroughani, R., Zaffaroni, M., Patti, F., Eichau, S., Salemi, G., Di Sapio, A., Inglese, M., Portaccio, E., Trojano, M., Amato, M. P., et al. (2024). Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries. The Lancet Child and Adolescent Health, 8(5), 348–357. https://doi.org/10.1016/S2352-4642(24)00047-6
Sharmin, S., Roos, I., Malpas, C. B., Iaffaldano, P., Simone, M., Filippi, M., Kubala Havrdova, E., Ozakbas, S., Brescia Morra, V., Alroughani, R., Zaffaroni, M., Patti, F., Eichau, S., Salemi, G., Di Sapio, A., Inglese, M., Portaccio, E., Trojano, M., Amato, M. P., et al. (2024). Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries. The Lancet Child and Adolescent Health, 8(5), 348–357. https://doi.org/10.1016/S2352-4642(24)00047-6
Hirt, Julian, Janiaud, Perrine, Düblin, Pascal, Nicoletti, Giovanni Jacopo, Dembowska, Kinga, Nguyen, Thao Vy Thi, Woelfle, Tim, Axfors, Cathrine, Yaldizli, Özgür, Granziera, Cristina, Multiple Sclerosis Journal, 30(4-5), 463–478. https://doi.org/10.1177/13524585231221938
, Kappos, Ludwig, & Hemkens, Lars G. (2024). Use of pragmatic randomized trials in multiple sclerosis: A systematic overview.
Hirt, Julian, Janiaud, Perrine, Düblin, Pascal, Nicoletti, Giovanni Jacopo, Dembowska, Kinga, Nguyen, Thao Vy Thi, Woelfle, Tim, Axfors, Cathrine, Yaldizli, Özgür, Granziera, Cristina, Multiple Sclerosis Journal, 30(4-5), 463–478. https://doi.org/10.1177/13524585231221938
, Kappos, Ludwig, & Hemkens, Lars G. (2024). Use of pragmatic randomized trials in multiple sclerosis: A systematic overview.
Montalban, Xavier, Piasecka-Stryczynska, Karolina, Multiple Sclerosis Journal, 30(4-5), 558–570. https://doi.org/10.1177/13524585241234783
, Benkert, Pascal, Arnold, Douglas L, Weber, Martin S, Seitzinger, Andrea, Guehring, Hans, Shaw, Jamie, Tomic, Davorka, Hyvert, Yann, Harlow, Danielle E, Dyroff, Martin, & Wolinsky, Jerry S. (2024). Efficacy and safety results after > 3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study.
Montalban, Xavier, Piasecka-Stryczynska, Karolina, Multiple Sclerosis Journal, 30(4-5), 558–570. https://doi.org/10.1177/13524585241234783
, Benkert, Pascal, Arnold, Douglas L, Weber, Martin S, Seitzinger, Andrea, Guehring, Hans, Shaw, Jamie, Tomic, Davorka, Hyvert, Yann, Harlow, Danielle E, Dyroff, Martin, & Wolinsky, Jerry S. (2024). Efficacy and safety results after > 3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study.
Queissner, R., Buchmann, A., Demjaha, R., Tafrali, C., Benkert, P., Journal of Affective Disorders, 350, 366–371. https://doi.org/10.1016/j.jad.2024.01.088
, Jerkovic, A., Dalkner, N., Fellendorf, F., Birner, A., Platzer, M., Tmava-Berisha, A., Maget, A., Stross, T., Lenger, M., Häussl, A., Khalil, M., & Reininghaus, E. (2024). Serum neurofilament light as a potential marker of illness duration in bipolar disorder.
Queissner, R., Buchmann, A., Demjaha, R., Tafrali, C., Benkert, P., Journal of Affective Disorders, 350, 366–371. https://doi.org/10.1016/j.jad.2024.01.088
, Jerkovic, A., Dalkner, N., Fellendorf, F., Birner, A., Platzer, M., Tmava-Berisha, A., Maget, A., Stross, T., Lenger, M., Häussl, A., Khalil, M., & Reininghaus, E. (2024). Serum neurofilament light as a potential marker of illness duration in bipolar disorder.
Spelman, T., Eichau, S., Alroughani, R., Ozakbas, S., Khoury, S. J., Patti, F., Kubala Havrdova, E., Boz, C., Terzi, M., Kuhle, J., Grammond, P., Lechner-Scott, J., Gray, O., Amato, M. P., Laureys, G., Shaygannejad, V., Hyde, R., Wang, H., Bozin, I., et al. (2024). Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 10(2). https://doi.org/10.1177/20552173241247182
Spelman, T., Eichau, S., Alroughani, R., Ozakbas, S., Khoury, S. J., Patti, F., Kubala Havrdova, E., Boz, C., Terzi, M., Kuhle, J., Grammond, P., Lechner-Scott, J., Gray, O., Amato, M. P., Laureys, G., Shaygannejad, V., Hyde, R., Wang, H., Bozin, I., et al. (2024). Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 10(2). https://doi.org/10.1177/20552173241247182
Janiaud, Perrine, Zecca, Chiara, Salmen, Anke, Benkert, Pascal, Schädelin, Sabine, Orleth, Annette, Demuth, Lilian, Maceski, Aleksandra Maleska, Granziera, Cristina, Oechtering, Johanna, Leppert, David, Derfuss, Tobias, Achtnichts, Lutz, Findling, Oliver, Roth, Patrick, Lalive, Patrice, Uginet, Marjolaine, Müller, Stefanie, Pot, Caroline, et al. (2024). MultiSCRIPT-Cycle 1- A Pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in Multiple Sclerosis: a study protocol for a randomized clinical trial [Posted-content]. In medRxiv. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.03.22.24304720
Janiaud, Perrine, Zecca, Chiara, Salmen, Anke, Benkert, Pascal, Schädelin, Sabine, Orleth, Annette, Demuth, Lilian, Maceski, Aleksandra Maleska, Granziera, Cristina, Oechtering, Johanna, Leppert, David, Derfuss, Tobias, Achtnichts, Lutz, Findling, Oliver, Roth, Patrick, Lalive, Patrice, Uginet, Marjolaine, Müller, Stefanie, Pot, Caroline, et al. (2024). MultiSCRIPT-Cycle 1- A Pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in Multiple Sclerosis: a study protocol for a randomized clinical trial [Posted-content]. In medRxiv. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.03.22.24304720
Wang, Angela A., Luessi, Felix, Neziraj, Tradite, Pössnecker, Elisabeth, Zuo, Michelle, Engel, Sinah, Hanuscheck, Nicholas, Florescu, Alexandra, Bugbee, Eryn, Ma, Xianjie I., Rana, Fatima, Lee, Dennis, Ward, Lesley A., Science Translational Medicine, 16(737). https://doi.org/10.1126/scitranslmed.adi0295
, Himbert, Johannes, Schraad, Muriel, van Puijenbroek, Erwin, Klein, Christian, Urich, Eduard, et al. (2024). B cell depletion with anti-CD20 promotes neuroprotection in a BAFF-dependent manner in mice and humans.
Wang, Angela A., Luessi, Felix, Neziraj, Tradite, Pössnecker, Elisabeth, Zuo, Michelle, Engel, Sinah, Hanuscheck, Nicholas, Florescu, Alexandra, Bugbee, Eryn, Ma, Xianjie I., Rana, Fatima, Lee, Dennis, Ward, Lesley A., Science Translational Medicine, 16(737). https://doi.org/10.1126/scitranslmed.adi0295
, Himbert, Johannes, Schraad, Muriel, van Puijenbroek, Erwin, Klein, Christian, Urich, Eduard, et al. (2024). B cell depletion with anti-CD20 promotes neuroprotection in a BAFF-dependent manner in mice and humans.
Callegari, Ilaria, Oechtering, Johanna, Schneider, Mika, Perriot, Sylvain, Mathias, Amandine, Voortman, Margarete M., Cagol, Alessandro, Lanner, Ulrike, Diebold, Martin, Holdermann, Sebastian, Kreiner, Victor, Becher, Burkhard, Granziera, Cristina, Junker, Andreas, Pasquier, Renaud Du, Khalil, Michael, Brain, 147(3), 839–848. https://doi.org/10.1093/brain/awad424
, Kappos, Ludwig, Sanderson, Nicholas S.R., & Derfuss, Tobias. (2024). Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5.
Callegari, Ilaria, Oechtering, Johanna, Schneider, Mika, Perriot, Sylvain, Mathias, Amandine, Voortman, Margarete M., Cagol, Alessandro, Lanner, Ulrike, Diebold, Martin, Holdermann, Sebastian, Kreiner, Victor, Becher, Burkhard, Granziera, Cristina, Junker, Andreas, Pasquier, Renaud Du, Khalil, Michael, Brain, 147(3), 839–848. https://doi.org/10.1093/brain/awad424
, Kappos, Ludwig, Sanderson, Nicholas S.R., & Derfuss, Tobias. (2024). Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5.
Freedman, Mark S., Gnanapavan, Sharmilee, Booth, Ronald A., Calabresi, Peter A., Khalil, Michael, eBioMedicine, 101. https://doi.org/10.1016/j.ebiom.2024.104970
, Lycke, Jan, & Olsson, Tomas. (2024). Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management.
Freedman, Mark S., Gnanapavan, Sharmilee, Booth, Ronald A., Calabresi, Peter A., Khalil, Michael, eBioMedicine, 101. https://doi.org/10.1016/j.ebiom.2024.104970
, Lycke, Jan, & Olsson, Tomas. (2024). Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management.
Geis, T., Gutzeit, S., Disse, S., Kuhle, J., Fouzas, S., & Wellmann, S. (2024). Neurofilament Light Chain Concentration in Cerebrospinal Fluid in Children with Acute Nontraumatic Neurological Disorders. Children, 11(3). https://doi.org/10.3390/children11030360
Geis, T., Gutzeit, S., Disse, S., Kuhle, J., Fouzas, S., & Wellmann, S. (2024). Neurofilament Light Chain Concentration in Cerebrospinal Fluid in Children with Acute Nontraumatic Neurological Disorders. Children, 11(3). https://doi.org/10.3390/children11030360
Rusche, Thilo, Yaldizli, Özgür, Galbusera, Riccardo, Mutke, Matthias, Halter, Jörg P, Lieb, Johanna, Matteazzi, Francesca, Stelmes, Anne, Bittner, Jan, Grzonka, Pascale, Frank, Nicole, Cordier, Dominik, Hench, Jürgen, Frank, Stephan, Hirsch, Hans H, Fischer, Urs, The Lancet, 403(10425), 469–470. https://doi.org/10.1016/S0140-6736(23)02831-3
, Sutter, Raoul, Rüegg, Stephan, & Fisch, Urs. (2024). Anti-GABAA receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia.
Rusche, Thilo, Yaldizli, Özgür, Galbusera, Riccardo, Mutke, Matthias, Halter, Jörg P, Lieb, Johanna, Matteazzi, Francesca, Stelmes, Anne, Bittner, Jan, Grzonka, Pascale, Frank, Nicole, Cordier, Dominik, Hench, Jürgen, Frank, Stephan, Hirsch, Hans H, Fischer, Urs, The Lancet, 403(10425), 469–470. https://doi.org/10.1016/S0140-6736(23)02831-3
, Sutter, Raoul, Rüegg, Stephan, & Fisch, Urs. (2024). Anti-GABAA receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia.
Rusche, Thilo, Yaldizli, Özgür, Galbusera, Riccardo, Mutke, Matthias, Halter, Jörg P, Lieb, Johanna, Matteazzi, Francesca, Stelmes, Anne, Bittner, Jan, Grzonka, Pascale, Frank, Nicole, Cordier, Dominik, Hench, Jürgen, Frank, Stephan, Hirsch, Hans H, Fischer, Urs, The Lancet, 403(10425), 469–470. https://doi.org/10.1016/s0140-6736(23)02831-3
, Sutter, Raoul, Rüegg, Stephan, & Fisch, Urs. (2024). Anti-GABAA receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia [Journal-article].
Rusche, Thilo, Yaldizli, Özgür, Galbusera, Riccardo, Mutke, Matthias, Halter, Jörg P, Lieb, Johanna, Matteazzi, Francesca, Stelmes, Anne, Bittner, Jan, Grzonka, Pascale, Frank, Nicole, Cordier, Dominik, Hench, Jürgen, Frank, Stephan, Hirsch, Hans H, Fischer, Urs, The Lancet, 403(10425), 469–470. https://doi.org/10.1016/s0140-6736(23)02831-3
, Sutter, Raoul, Rüegg, Stephan, & Fisch, Urs. (2024). Anti-GABAA receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia [Journal-article].
Abdelhak, Ahmed, Antweiler, Kai, Kowarik, Markus C., Senel, Makbule, Havla, Joachim, Zettl, Uwe K., Kleiter, Ingo, Skripuletz, Thomas, Haarmann, Axel, Stahmann, Alexander, Huss, Andre, Gingele, Stefan, Krumbholz, Markus, Benkert, Pascal, Annals of Clinical and Translational Neurology, 11(2), 477–485. https://doi.org/10.1002/acn3.51969
, Friede, Tim, Ludolph, Albert C., Ziemann, Ulf, Kümpfel, Tania, & Tumani, Hayrettin. (2024). Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis.
Abdelhak, Ahmed, Antweiler, Kai, Kowarik, Markus C., Senel, Makbule, Havla, Joachim, Zettl, Uwe K., Kleiter, Ingo, Skripuletz, Thomas, Haarmann, Axel, Stahmann, Alexander, Huss, Andre, Gingele, Stefan, Krumbholz, Markus, Benkert, Pascal, Annals of Clinical and Translational Neurology, 11(2), 477–485. https://doi.org/10.1002/acn3.51969
, Friede, Tim, Ludolph, Albert C., Ziemann, Ulf, Kümpfel, Tania, & Tumani, Hayrettin. (2024). Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis.
Hermesdorf, Marco, Wulms, Niklas, Maceski, Aleksandra, Leppert, David, Benkert, Pascal, Wiendl, Heinz, GeroScience, 46(1), 463–472. https://doi.org/10.1007/s11357-023-00846-x
, & Berger, Klaus. (2024). Serum neurofilament light and white matter characteristics in the general population: a longitudinal analysis.
Hermesdorf, Marco, Wulms, Niklas, Maceski, Aleksandra, Leppert, David, Benkert, Pascal, Wiendl, Heinz, GeroScience, 46(1), 463–472. https://doi.org/10.1007/s11357-023-00846-x
, & Berger, Klaus. (2024). Serum neurofilament light and white matter characteristics in the general population: a longitudinal analysis.
Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Muller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS. Neurology, 102(1). https://doi.org/10.1212/WNL.0000000000207768
Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Muller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS. Neurology, 102(1). https://doi.org/10.1212/WNL.0000000000207768
Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Müller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS [Journal-article]. Neurology, 102(1). https://doi.org/10.1212/wnl.0000000000207768
Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Müller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS [Journal-article]. Neurology, 102(1). https://doi.org/10.1212/wnl.0000000000207768
Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Müller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS [Journal-article]. Neurology, 102(1). https://doi.org/10.1212/wnl.0000000000207768
Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Müller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS [Journal-article]. Neurology, 102(1). https://doi.org/10.1212/wnl.0000000000207768
Pontillo, G., Prados, F., Colman, J., Kanber, B., Abdel-Mannan, O., Al-Araji, S., Ballenberg, B., Bianchi, A., Bisecco, A., Brownlee, W., Brunetti, A., Cagol, A., Calabrese, M., Castellaro, M., Christensen, R., Cocozza, S., Colato, E., Collorone, S., Cortese, R., et al. (2024). Disentangling neurodegeneration from ageing in multiple sclerosis: the brain-predicted disease duration gap [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.01.02.23300497
Pontillo, G., Prados, F., Colman, J., Kanber, B., Abdel-Mannan, O., Al-Araji, S., Ballenberg, B., Bianchi, A., Bisecco, A., Brownlee, W., Brunetti, A., Cagol, A., Calabrese, M., Castellaro, M., Christensen, R., Cocozza, S., Colato, E., Collorone, S., Cortese, R., et al. (2024). Disentangling neurodegeneration from ageing in multiple sclerosis: the brain-predicted disease duration gap [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.01.02.23300497
Wilson, David, Chan, Dandan, Chang, Lei, Mathis, Robert, Verberk, Inge, Montalban, Xavier, Comabella, Manuel, Fissolo, Nicolas, Bielekova, Bibi, Masvekar, Ruturaj, Chitnis, Tanuja, Ziemssen, Tjalf, Akgün, Katja, Blennow, Kaj, Zetterberg, Henrik, Brück, Wolfgang, Giovannoni, Gavin, Gnanapavan, Sharmilee, Bittner, Stefan, et al. (2024). Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury. Clinical Chemistry and Laboratory Medicine, 62(2), 322–331. https://doi.org/10.1515/cclm-2023-0518
Wilson, David, Chan, Dandan, Chang, Lei, Mathis, Robert, Verberk, Inge, Montalban, Xavier, Comabella, Manuel, Fissolo, Nicolas, Bielekova, Bibi, Masvekar, Ruturaj, Chitnis, Tanuja, Ziemssen, Tjalf, Akgün, Katja, Blennow, Kaj, Zetterberg, Henrik, Brück, Wolfgang, Giovannoni, Gavin, Gnanapavan, Sharmilee, Bittner, Stefan, et al. (2024). Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury. Clinical Chemistry and Laboratory Medicine, 62(2), 322–331. https://doi.org/10.1515/cclm-2023-0518
Kagerer, Sonja M., Awasthi, Swapnil, Ripke, Stephan, Maceski, Aleksandra, Benkert, Pascal, Fall, Aïda B., Riederer, Peter, Fischer, Peter, Walitza, Susanne, Grünblatt, Edna, Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring, 16(1). https://doi.org/10.1002/dad2.12504
, & Unschuld, Paul G. (2024). Polygenic risk for Alzheimer’s disease is associated with neuroaxonal damage before onset of clinical symptoms.
Kagerer, Sonja M., Awasthi, Swapnil, Ripke, Stephan, Maceski, Aleksandra, Benkert, Pascal, Fall, Aïda B., Riederer, Peter, Fischer, Peter, Walitza, Susanne, Grünblatt, Edna, Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring, 16(1). https://doi.org/10.1002/dad2.12504
, & Unschuld, Paul G. (2024). Polygenic risk for Alzheimer’s disease is associated with neuroaxonal damage before onset of clinical symptoms.
Kuhle, J. (2024). Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a post hoc analysis. Therapeutic Advances in Neurological Disorders, 17. https://doi.org/10.1177/17562864241239101
Kuhle, J. (2024). Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a post hoc analysis. Therapeutic Advances in Neurological Disorders, 17. https://doi.org/10.1177/17562864241239101
Dekeyser, C., Hautekeete, M., Cambron, M., Van Pesch, V., Patti, F., Kuhle, J., Khoury, S., Lechner Scott, J., Gerlach, O., Lugaresi, A., Maimone, D., Surcinelli, A., Grammond, P., Kalincik, T., Habek, M., Willekens, B., Macdonell, R., Lalive, P., Csepany, T., et al. (2024). Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study [Journal-article]. Journal of Neurology, Neurosurgery and Psychiatry, jnnp–2023. https://doi.org/10.1136/jnnp-2023-333307
Dekeyser, C., Hautekeete, M., Cambron, M., Van Pesch, V., Patti, F., Kuhle, J., Khoury, S., Lechner Scott, J., Gerlach, O., Lugaresi, A., Maimone, D., Surcinelli, A., Grammond, P., Kalincik, T., Habek, M., Willekens, B., Macdonell, R., Lalive, P., Csepany, T., et al. (2024). Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study [Journal-article]. Journal of Neurology, Neurosurgery and Psychiatry, jnnp–2023. https://doi.org/10.1136/jnnp-2023-333307
Galbusera, Riccardo, Bahn, Erik, Weigel, Matthias, Cagol, Alessandro, Lu, Po-Jui, Schaedelin, Sabine A., Franz, Jonas, Barakovic, Muhamed, Rahmanzadeh, Reza, Dechent, Peter, Nair, Govind, Brück, Wolfgang, Neurology, 102(3), e207966. https://doi.org/10.1212/WNL.0000000000207966
, Kappos, Ludwig, Stadelmann, Christine, & Granziera, Cristina. (2023). Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis.
Galbusera, Riccardo, Bahn, Erik, Weigel, Matthias, Cagol, Alessandro, Lu, Po-Jui, Schaedelin, Sabine A., Franz, Jonas, Barakovic, Muhamed, Rahmanzadeh, Reza, Dechent, Peter, Nair, Govind, Brück, Wolfgang, Neurology, 102(3), e207966. https://doi.org/10.1212/WNL.0000000000207966
, Kappos, Ludwig, Stadelmann, Christine, & Granziera, Cristina. (2023). Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis.
Galbusera, Riccardo, Bahn, Erik, Weigel, Matthias, Cagol, Alessandro, Lu, Po-Jui, Schaedelin, Sabine A., Franz, Jonas, Barakovic, Muhamed, Rahmanzadeh, Reza, Dechent, Peter, Nair, Govind, Brück, Wolfgang, Neurology, 102(3). https://doi.org/10.1212/wnl.0000000000207966
, Kappos, Ludwig, Stadelmann, Christine, & Granziera, Cristina. (2023). Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis [Journal-article].
Galbusera, Riccardo, Bahn, Erik, Weigel, Matthias, Cagol, Alessandro, Lu, Po-Jui, Schaedelin, Sabine A., Franz, Jonas, Barakovic, Muhamed, Rahmanzadeh, Reza, Dechent, Peter, Nair, Govind, Brück, Wolfgang, Neurology, 102(3). https://doi.org/10.1212/wnl.0000000000207966
, Kappos, Ludwig, Stadelmann, Christine, & Granziera, Cristina. (2023). Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis [Journal-article].
Abdelhak, Ahmed, Benkert, Pascal, Schaedelin, Sabine, Boscardin, W. John, Cordano, Christian, Oechtering, Johanna, Ananth, Kirtana, Granziera, Cristina, Melie-Garcia, Lester, Montes, Shivany Condor, Beaudry-Richard, Alexandra, Achtnichts, Lutz, Oertel, Frederike C., Lalive, Patrice H., Leppert, David, Müller, Stefanie, Henry, Roland G., Pot, Caroline, Matthias, Amandine, et al. (2023). Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis. JAMA Neurology, 80(12), 1317–1325. https://doi.org/10.1001/jamaneurol.2023.3997
Abdelhak, Ahmed, Benkert, Pascal, Schaedelin, Sabine, Boscardin, W. John, Cordano, Christian, Oechtering, Johanna, Ananth, Kirtana, Granziera, Cristina, Melie-Garcia, Lester, Montes, Shivany Condor, Beaudry-Richard, Alexandra, Achtnichts, Lutz, Oertel, Frederike C., Lalive, Patrice H., Leppert, David, Müller, Stefanie, Henry, Roland G., Pot, Caroline, Matthias, Amandine, et al. (2023). Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis. JAMA Neurology, 80(12), 1317–1325. https://doi.org/10.1001/jamaneurol.2023.3997
Abdelhak, Ahmed, Benkert, Pascal, Schaedelin, Sabine, Boscardin, W. John, Cordano, Christian, Oechtering, Johanna, Ananth, Kirtana, Granziera, Cristina, Melie-Garcia, Lester, Montes, Shivany Condor, Beaudry-Richard, Alexandra, Achtnichts, Lutz, Oertel, Frederike C., Lalive, Patrice H., Leppert, David, Müller, Stefanie, Henry, Roland G., Pot, Caroline, Matthias, Amandine, et al. (2023). Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis [Journal-article]. JAMA Neurology, 80(12), 1317–1325. https://doi.org/10.1001/jamaneurol.2023.3997
Abdelhak, Ahmed, Benkert, Pascal, Schaedelin, Sabine, Boscardin, W. John, Cordano, Christian, Oechtering, Johanna, Ananth, Kirtana, Granziera, Cristina, Melie-Garcia, Lester, Montes, Shivany Condor, Beaudry-Richard, Alexandra, Achtnichts, Lutz, Oertel, Frederike C., Lalive, Patrice H., Leppert, David, Müller, Stefanie, Henry, Roland G., Pot, Caroline, Matthias, Amandine, et al. (2023). Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis [Journal-article]. JAMA Neurology, 80(12), 1317–1325. https://doi.org/10.1001/jamaneurol.2023.3997
Lipps, Patrick, Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Kulsvehagen, Laila, Mutke, Matthias Anthony, JAMA Neurology, 80(12), 1377–1379. https://doi.org/10.1001/jamaneurol.2023.3956
, Papadopoulou, Athina, & Pröbstel, Anne-Katrin. (2023). Ongoing Challenges in the Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Lipps, Patrick, Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Kulsvehagen, Laila, Mutke, Matthias Anthony, JAMA Neurology, 80(12), 1377–1379. https://doi.org/10.1001/jamaneurol.2023.3956
, Papadopoulou, Athina, & Pröbstel, Anne-Katrin. (2023). Ongoing Challenges in the Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Leone, Maurizio A., Gelati, Maurizio, Profico, Daniela C., Gobbi, Claudio, Pravatà, Emanuele, Copetti, Massimiliano, Conti, Carlo, Abate, Lucrezia, Amoruso, Luigi, Apollo, Francesco, Balzano, Rosario F., Bicchi, Ilaria, Carella, Massimo, Ciampini, Alessandro, Colosimo, Carlo, Crociani, Paola, D’Aloisio, Giada, Di Viesti, Pietro, Ferrari, Daniela, et al. (2023). Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis. Cell Stem Cell, 30(12), 1597–1609. https://doi.org/10.1016/j.stem.2023.11.001
Leone, Maurizio A., Gelati, Maurizio, Profico, Daniela C., Gobbi, Claudio, Pravatà, Emanuele, Copetti, Massimiliano, Conti, Carlo, Abate, Lucrezia, Amoruso, Luigi, Apollo, Francesco, Balzano, Rosario F., Bicchi, Ilaria, Carella, Massimo, Ciampini, Alessandro, Colosimo, Carlo, Crociani, Paola, D’Aloisio, Giada, Di Viesti, Pietro, Ferrari, Daniela, et al. (2023). Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis. Cell Stem Cell, 30(12), 1597–1609. https://doi.org/10.1016/j.stem.2023.11.001
Leone, Maurizio A., Gelati, Maurizio, Profico, Daniela C., Gobbi, Claudio, Pravatà, Emanuele, Copetti, Massimiliano, Conti, Carlo, Abate, Lucrezia, Amoruso, Luigi, Apollo, Francesco, Balzano, Rosario F., Bicchi, Ilaria, Carella, Massimo, Ciampini, Alessandro, Colosimo, Carlo, Crociani, Paola, D’Aloisio, Giada, Di Viesti, Pietro, Ferrari, Daniela, et al. (2023). Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis [Journal-article]. Cell Stem Cell, 30(12), 1597–1609. https://doi.org/10.1016/j.stem.2023.11.001
Leone, Maurizio A., Gelati, Maurizio, Profico, Daniela C., Gobbi, Claudio, Pravatà, Emanuele, Copetti, Massimiliano, Conti, Carlo, Abate, Lucrezia, Amoruso, Luigi, Apollo, Francesco, Balzano, Rosario F., Bicchi, Ilaria, Carella, Massimo, Ciampini, Alessandro, Colosimo, Carlo, Crociani, Paola, D’Aloisio, Giada, Di Viesti, Pietro, Ferrari, Daniela, et al. (2023). Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis [Journal-article]. Cell Stem Cell, 30(12), 1597–1609. https://doi.org/10.1016/j.stem.2023.11.001
Disanto, Giulio, Villa, Michele, Maleska Maceski, Aleksandra, Prosperetti, Chiara, Gobbi, Claudio, Annals of Clinical and Translational Neurology, 10(12), 2407–2412. https://doi.org/10.1002/acn3.51903
, Cassina, Tiziano, & Agazzi, Pamela. (2023). Longitudinal serum neurofilament light kinetics in post-anoxic encephalopathy.
Disanto, Giulio, Villa, Michele, Maleska Maceski, Aleksandra, Prosperetti, Chiara, Gobbi, Claudio, Annals of Clinical and Translational Neurology, 10(12), 2407–2412. https://doi.org/10.1002/acn3.51903
, Cassina, Tiziano, & Agazzi, Pamela. (2023). Longitudinal serum neurofilament light kinetics in post-anoxic encephalopathy.
Disanto, Giulio, Villa, Michele, Maleska Maceski, Aleksandra, Prosperetti, Chiara, Gobbi, Claudio, Annals of Clinical and Translational Neurology, 10(12), 2407–2412. https://doi.org/10.1002/acn3.51903
, Cassina, Tiziano, & Agazzi, Pamela. (2023). Longitudinal serum neurofilament light kinetics in post-anoxic encephalopathy [Journal-article].
Disanto, Giulio, Villa, Michele, Maleska Maceski, Aleksandra, Prosperetti, Chiara, Gobbi, Claudio, Annals of Clinical and Translational Neurology, 10(12), 2407–2412. https://doi.org/10.1002/acn3.51903
, Cassina, Tiziano, & Agazzi, Pamela. (2023). Longitudinal serum neurofilament light kinetics in post-anoxic encephalopathy [Journal-article].
Körtvelyessy, Peter, Diekämper, Elena, Ruprecht, Klemens, Endres, Matthias, Stubbemann, Paula, Kurth, Florian, Graw, Jan Adriaan, Menk, Mario, European Journal of Medical Research, 28(1). https://doi.org/10.1186/s40001-023-01375-1
, & Wohlrab, Felix. (2023). Serum neurofilament light chain in COVID-19 and the influence of renal function.
Körtvelyessy, Peter, Diekämper, Elena, Ruprecht, Klemens, Endres, Matthias, Stubbemann, Paula, Kurth, Florian, Graw, Jan Adriaan, Menk, Mario, European Journal of Medical Research, 28(1). https://doi.org/10.1186/s40001-023-01375-1
, & Wohlrab, Felix. (2023). Serum neurofilament light chain in COVID-19 and the influence of renal function.
Müller, Jannis, Schädelin, Sabine, Lorscheider, Johannes, Benkert, Pascal, Hänni, Peter, Schmid, Jürg, European Journal of Neurology, 30(12), 3809–3818. https://doi.org/10.1111/ene.16044
, Derfuss, Tobias, Granziera, Cristina, & Yaldizli, Özgür. (2023). Comparative analysis of dimethyl fumarate and teriflunomide in relapsing–remitting multiple sclerosis.
Müller, Jannis, Schädelin, Sabine, Lorscheider, Johannes, Benkert, Pascal, Hänni, Peter, Schmid, Jürg, European Journal of Neurology, 30(12), 3809–3818. https://doi.org/10.1111/ene.16044
, Derfuss, Tobias, Granziera, Cristina, & Yaldizli, Özgür. (2023). Comparative analysis of dimethyl fumarate and teriflunomide in relapsing–remitting multiple sclerosis.
Overeem, Lucas Hendrik, Raffaelli, Bianca, Fleischmann, Robert, Süße, Marie, Vogelgesang, Antje, Maceski, Aleksandra Maleska, Papadopoulou, Athina, Ruprecht, Klemens, Su, Wendy, Koch, Mirja, Siebert, Anke, Arkuszewski, Michal, Tenenbaum, Nadia, Journal of Headache and Pain, 24(1). https://doi.org/10.1186/s10194-023-01663-5
, & Reuter, Uwe. (2023). Serum tau protein elevation in migraine: a cross-sectional case–control study.
Overeem, Lucas Hendrik, Raffaelli, Bianca, Fleischmann, Robert, Süße, Marie, Vogelgesang, Antje, Maceski, Aleksandra Maleska, Papadopoulou, Athina, Ruprecht, Klemens, Su, Wendy, Koch, Mirja, Siebert, Anke, Arkuszewski, Michal, Tenenbaum, Nadia, Journal of Headache and Pain, 24(1). https://doi.org/10.1186/s10194-023-01663-5
, & Reuter, Uwe. (2023). Serum tau protein elevation in migraine: a cross-sectional case–control study.
Sy, Michael, Newton, Barbara L., Pawling, Judy, Hayama, Ken L., Cordon, Andres, Yu, Zhaoxia, Journal of Neuroinflammation, 20(1). https://doi.org/10.1186/s12974-023-02893-9
, Dennis, James W., Brandt, Alexander U., & Demetriou, Michael. (2023). N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial.
Sy, Michael, Newton, Barbara L., Pawling, Judy, Hayama, Ken L., Cordon, Andres, Yu, Zhaoxia, Journal of Neuroinflammation, 20(1). https://doi.org/10.1186/s12974-023-02893-9
, Dennis, James W., Brandt, Alexander U., & Demetriou, Michael. (2023). N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial.
Müller, Jannis, Cagol, Alessandro, Lorscheider, Johannes, Tsagkas, Charidimos, Benkert, Pascal, Yaldizli, Özgür, JAMA Neurology, 80(11), 1232–1245. https://doi.org/10.1001/jamaneurol.2023.3331
, Derfuss, Tobias, Sormani, Maria Pia, Thompson, Alan, Granziera, Cristina, & Kappos, Ludwig. (2023). Harmonizing Definitions for Progression Independent of Relapse Activity inMultiple Sclerosis A Systematic Review.
Müller, Jannis, Cagol, Alessandro, Lorscheider, Johannes, Tsagkas, Charidimos, Benkert, Pascal, Yaldizli, Özgür, JAMA Neurology, 80(11), 1232–1245. https://doi.org/10.1001/jamaneurol.2023.3331
, Derfuss, Tobias, Sormani, Maria Pia, Thompson, Alan, Granziera, Cristina, & Kappos, Ludwig. (2023). Harmonizing Definitions for Progression Independent of Relapse Activity inMultiple Sclerosis A Systematic Review.
Müller, Jannis, Cagol, Alessandro, Lorscheider, Johannes, Tsagkas, Charidimos, Benkert, Pascal, Yaldizli, Özgür, JAMA Neurology, 80(11), 1232–1245. https://doi.org/10.1001/jamaneurol.2023.3331
, Derfuss, Tobias, Sormani, Maria Pia, Thompson, Alan, Granziera, Cristina, & Kappos, Ludwig. (2023). Harmonizing Definitions for Progression Independent of Relapse Activity inMultiple Sclerosis A Systematic Review [Journal-article].
Müller, Jannis, Cagol, Alessandro, Lorscheider, Johannes, Tsagkas, Charidimos, Benkert, Pascal, Yaldizli, Özgür, JAMA Neurology, 80(11), 1232–1245. https://doi.org/10.1001/jamaneurol.2023.3331
, Derfuss, Tobias, Sormani, Maria Pia, Thompson, Alan, Granziera, Cristina, & Kappos, Ludwig. (2023). Harmonizing Definitions for Progression Independent of Relapse Activity inMultiple Sclerosis A Systematic Review [Journal-article].
Cerdá-Fuertes, Nuria, Stoessel, Marc, Mickeliunas, Gintaras, Pless, Silvan, Cagol, Alessandro, Barakovic, Muhamed, Maceski, Aleksandra Maleska, Álvarez González, Cesar, D’ Souza, Marcus, Schaedlin, Sabine, Benkert, Pascal, Calabrese, Pasquale, Gugleta, Konstantin, Derfuss, Tobias, Sprenger, Till, Granziera, Cristina, Naegelin, Yvonne, Kappos, Ludwig, Kappos, Ludwig, et al. (2023). Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis. Multiple Sclerosis Journal, 29(13), 1540–1550. https://doi.org/10.1177/13524585231198760
Cerdá-Fuertes, Nuria, Stoessel, Marc, Mickeliunas, Gintaras, Pless, Silvan, Cagol, Alessandro, Barakovic, Muhamed, Maceski, Aleksandra Maleska, Álvarez González, Cesar, D’ Souza, Marcus, Schaedlin, Sabine, Benkert, Pascal, Calabrese, Pasquale, Gugleta, Konstantin, Derfuss, Tobias, Sprenger, Till, Granziera, Cristina, Naegelin, Yvonne, Kappos, Ludwig, Kappos, Ludwig, et al. (2023). Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis. Multiple Sclerosis Journal, 29(13), 1540–1550. https://doi.org/10.1177/13524585231198760
Rosenkranz, Sina C., Gutmann, Lilija, Has Silemek, Arzu Ceylan, Dorr, Michael, Häußler, Vivien, Lüpke, Margareta, Mönch, Andrea, Reinhardt, Stefanie, Journal of Neurology, Neurosurgery and Psychiatry, 94(11), 924–933. https://doi.org/10.1136/jnnp-2023-331183
, Tilsley, Penelope, Heesen, Christoph, Friese, Manuel A., Brandt, Alexander, Paul, Friedemann, Zimmermann, Hanna, & Stellmann, Jan-Patrick. (2023). Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis.
Rosenkranz, Sina C., Gutmann, Lilija, Has Silemek, Arzu Ceylan, Dorr, Michael, Häußler, Vivien, Lüpke, Margareta, Mönch, Andrea, Reinhardt, Stefanie, Journal of Neurology, Neurosurgery and Psychiatry, 94(11), 924–933. https://doi.org/10.1136/jnnp-2023-331183
, Tilsley, Penelope, Heesen, Christoph, Friese, Manuel A., Brandt, Alexander, Paul, Friedemann, Zimmermann, Hanna, & Stellmann, Jan-Patrick. (2023). Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis.
Sharmin, Sifat, Roos, Izanne, Simpson-Yap, Steve, Malpas, Charles, Sánchez, Marina M., Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva K., Patti, Francesco, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, Boz, Cavit, Zakaria, Magd, Onofrj, Marco, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Prat, Alexandre, Girard, Marc, et al. (2023). The risk of secondary progressive multiple sclerosis is geographically determined but modifiable. Brain, 146(11), 4633–4644. https://doi.org/10.1093/brain/awad218
Sharmin, Sifat, Roos, Izanne, Simpson-Yap, Steve, Malpas, Charles, Sánchez, Marina M., Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva K., Patti, Francesco, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, Boz, Cavit, Zakaria, Magd, Onofrj, Marco, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Prat, Alexandre, Girard, Marc, et al. (2023). The risk of secondary progressive multiple sclerosis is geographically determined but modifiable. Brain, 146(11), 4633–4644. https://doi.org/10.1093/brain/awad218
Callegari, I., Oechtering, J., Schneider, M., Perriot, S., Mathias, A., Voortman, M. M., Cagol, A., Lanner, U., Diebold, M., Holdermann, S., Kreiner, V., Becher, B., Granziera, C., Junker, A., Du Pasquier, R., Khalil, M., Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5 [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.09.29.560121
, Kappos, L., Sanderson, N., & Derfuss, T. (2023).
Callegari, I., Oechtering, J., Schneider, M., Perriot, S., Mathias, A., Voortman, M. M., Cagol, A., Lanner, U., Diebold, M., Holdermann, S., Kreiner, V., Becher, B., Granziera, C., Junker, A., Du Pasquier, R., Khalil, M., Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5 [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.09.29.560121
, Kappos, L., Sanderson, N., & Derfuss, T. (2023).
Uher, Tomas, Adzima, Adrian, Srpova, Barbora, Noskova, Libuse, Maréchal, Bénédicte, Maceski, Aleksandra Maleska, Krasensky, Jan, Stastna, Dominika, Andelova, Michaela, Novotna, Klara, Vodehnalova, Karolina, Motyl, Jiri, Friedova, Lucie, Lindner, Jiri, Ravano, Veronica, Burgetova, Andrea, Dusek, Petr, Fialova, Lenka, Havrdova, Eva Kubala, et al. (2023). Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences. Multiple Sclerosis Journal, 29(11-12), 1437–1451. https://doi.org/10.1177/13524585231197076
Uher, Tomas, Adzima, Adrian, Srpova, Barbora, Noskova, Libuse, Maréchal, Bénédicte, Maceski, Aleksandra Maleska, Krasensky, Jan, Stastna, Dominika, Andelova, Michaela, Novotna, Klara, Vodehnalova, Karolina, Motyl, Jiri, Friedova, Lucie, Lindner, Jiri, Ravano, Veronica, Burgetova, Andrea, Dusek, Petr, Fialova, Lenka, Havrdova, Eva Kubala, et al. (2023). Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences. Multiple Sclerosis Journal, 29(11-12), 1437–1451. https://doi.org/10.1177/13524585231197076
Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Kulsvehagen, Laila, Lipps, Patrick, Cagol, Alessandro, Cerdá-Fuertes, Nuria, Neziraj, Tradite, Flammer, Julia, Lerner, Jasmine, Lecourt, Anne-Catherine, De Oliveira S. Siebenborn, Nina, Cortese, Rosa, Schaedelin, Sabine, Andreoli Schoeps, Vinicius, De Moura Brasil Matos, Aline, Trombini Mendes, Natalia, Dos Reis Pereira, Clarissa, Ribeiro Monteiro, Mario Luiz, Dos Apóstolos-Pereira, Samira Luisa, Schindler, Patrick, et al. (2023). Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients with Central Nervous System Demyelination. JAMA Neurology, 80(9), 989–995. https://doi.org/10.1001/jamaneurol.2023.2523
Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Kulsvehagen, Laila, Lipps, Patrick, Cagol, Alessandro, Cerdá-Fuertes, Nuria, Neziraj, Tradite, Flammer, Julia, Lerner, Jasmine, Lecourt, Anne-Catherine, De Oliveira S. Siebenborn, Nina, Cortese, Rosa, Schaedelin, Sabine, Andreoli Schoeps, Vinicius, De Moura Brasil Matos, Aline, Trombini Mendes, Natalia, Dos Reis Pereira, Clarissa, Ribeiro Monteiro, Mario Luiz, Dos Apóstolos-Pereira, Samira Luisa, Schindler, Patrick, et al. (2023). Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients with Central Nervous System Demyelination. JAMA Neurology, 80(9), 989–995. https://doi.org/10.1001/jamaneurol.2023.2523
Abdelhak, Ahmed, Petermeier, Franziska, Benkert, Pascal, Schädelin, Sabine, Oechtering, Johanna, Maleska Maceski, Aleksandra, Kabesch, Michael, Geis, Tobias, Laub, Otto, Leipold, Georg, Gobbi, Claudio, Zecca, Chiara, Green, Ari, Tumani, Hayrettin, Willemse, Eline, Wiendl, Heinz, Granziera, Cristina, Kappos, Ludwig, Leppert, David, et al. (2023). Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study. The Lancet Neurology, 22(9), 826–833. https://doi.org/10.1016/S1474-4422(23)00210-7
Abdelhak, Ahmed, Petermeier, Franziska, Benkert, Pascal, Schädelin, Sabine, Oechtering, Johanna, Maleska Maceski, Aleksandra, Kabesch, Michael, Geis, Tobias, Laub, Otto, Leipold, Georg, Gobbi, Claudio, Zecca, Chiara, Green, Ari, Tumani, Hayrettin, Willemse, Eline, Wiendl, Heinz, Granziera, Cristina, Kappos, Ludwig, Leppert, David, et al. (2023). Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study. The Lancet Neurology, 22(9), 826–833. https://doi.org/10.1016/S1474-4422(23)00210-7
Harding-Forrester, Sam, Roos, Izanne, Nguyen, Ai-Lan, Malpas, Charles B, Diouf, Ibrahima, Moradi, Nahid, Sharmin, Sifat, Izquierdo, Guillermo, Eichau, Sara, Patti, Francesco, Horakova, Dana, Kubala Havrdova, Eva, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grand’Maison, Francois, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, et al. (2023). Disability accrual in primary and secondary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94(9), 707–717. https://doi.org/10.1136/jnnp-2022-330726
Harding-Forrester, Sam, Roos, Izanne, Nguyen, Ai-Lan, Malpas, Charles B, Diouf, Ibrahima, Moradi, Nahid, Sharmin, Sifat, Izquierdo, Guillermo, Eichau, Sara, Patti, Francesco, Horakova, Dana, Kubala Havrdova, Eva, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grand’Maison, Francois, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, et al. (2023). Disability accrual in primary and secondary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94(9), 707–717. https://doi.org/10.1136/jnnp-2022-330726
Leppert, David, Watanabe, Mitsuru, Schaedelin, Sabine, Piehl, Fredrik, Furlan, Roberto, Gastaldi, Matteo, Lambert, Jeremy, Evertsson, Björn, Fink, Katharina, Matsushita, Takuya, Masaki, Katsuhisa, Isobe, Noriko, Kira, Jun-Ichi, Benkert, Pascal, Maceski, Aleksandra, Willemse, Eline, Oechtering, Johanna, Orleth, Annette, Meier, Stephanie, & Journal of Neurology, Neurosurgery and Psychiatry, 94(9), 726–737. https://doi.org/10.1136/jnnp-2022-330796
. (2023). Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis.
Leppert, David, Watanabe, Mitsuru, Schaedelin, Sabine, Piehl, Fredrik, Furlan, Roberto, Gastaldi, Matteo, Lambert, Jeremy, Evertsson, Björn, Fink, Katharina, Matsushita, Takuya, Masaki, Katsuhisa, Isobe, Noriko, Kira, Jun-Ichi, Benkert, Pascal, Maceski, Aleksandra, Willemse, Eline, Oechtering, Johanna, Orleth, Annette, Meier, Stephanie, & Journal of Neurology, Neurosurgery and Psychiatry, 94(9), 726–737. https://doi.org/10.1136/jnnp-2022-330796
. (2023). Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis.
Saraste, Maija, Matilainen, Markus, Vuorimaa, Anna, Laaksonen, Sini, Sucksdorff, Marcus, Leppert, David, Journal of Neurology, Neurosurgery and Psychiatry, 94(9), 698–706. https://doi.org/10.1136/jnnp-2023-331051
, & Airas, Laura. (2023). Association of serum neurofilament light with microglial activation in multiple sclerosis.
Saraste, Maija, Matilainen, Markus, Vuorimaa, Anna, Laaksonen, Sini, Sucksdorff, Marcus, Leppert, David, Journal of Neurology, Neurosurgery and Psychiatry, 94(9), 698–706. https://doi.org/10.1136/jnnp-2023-331051
, & Airas, Laura. (2023). Association of serum neurofilament light with microglial activation in multiple sclerosis.
Todea, Alexandra Ramona, Melie-Garcia, Lester, Barakovic, Muhamed, Cagol, Alessandro, Rahmanzadeh, Reza, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Schaedelin, Sabine, Benkert, Pascal, Oezguer, Yaldizli, Sinnecker, Tim, Müller, Stefanie, Achtnichts, Lutz, Vehoff, Jochen, Disanto, Giulio, Findling, Oliver, et al. (2023). A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients. Journal of Magnetic Resonance Imaging, 58(3), 864–876. https://doi.org/10.1002/jmri.28618
Todea, Alexandra Ramona, Melie-Garcia, Lester, Barakovic, Muhamed, Cagol, Alessandro, Rahmanzadeh, Reza, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Schaedelin, Sabine, Benkert, Pascal, Oezguer, Yaldizli, Sinnecker, Tim, Müller, Stefanie, Achtnichts, Lutz, Vehoff, Jochen, Disanto, Giulio, Findling, Oliver, et al. (2023). A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients. Journal of Magnetic Resonance Imaging, 58(3), 864–876. https://doi.org/10.1002/jmri.28618
Roos, Izanne, Hughes, Stella, McDonnell, Gavin, Malpas, Charles B., Sharmin, Sifat, Boz, Cavit, Alroughani, Raed, Ozakbas, Serkan, Buzzard, Katherine, Skibina, Olga, Van Der Walt, Anneke, Butzkueven, Helmut, Lechner-Scott, Jeannette, JAMA Neurology, 80(8), 789–797. https://doi.org/10.1001/jamaneurol.2023.1625
, Terzi, Murat, Laureys, Guy, Van Hijfte, Liesbeth, John, Nevin, Grammond, Pierre, et al. (2023). Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis.
Roos, Izanne, Hughes, Stella, McDonnell, Gavin, Malpas, Charles B., Sharmin, Sifat, Boz, Cavit, Alroughani, Raed, Ozakbas, Serkan, Buzzard, Katherine, Skibina, Olga, Van Der Walt, Anneke, Butzkueven, Helmut, Lechner-Scott, Jeannette, JAMA Neurology, 80(8), 789–797. https://doi.org/10.1001/jamaneurol.2023.1625
, Terzi, Murat, Laureys, Guy, Van Hijfte, Liesbeth, John, Nevin, Grammond, Pierre, et al. (2023). Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis.
Spelman, Tim, Ozakbas, Serkan, Alroughani, Raed, Terzi, Murat, Hodgkinson, Suzanne, Laureys, Guy, Kalincik, Tomas, Der Walt, Anneke Van, Yamout, Bassem, Lechner-Scott, Jeannette, Soysal, Aysun, Neurodegenerative Disease Management, 13(4), 215–221. https://doi.org/10.2217/nmt-2023-0005
, Sanchez-Menoyo, Jose Luis, Morgado, Yolanda Blanco, Spitaleri, Daniele L.A., Pesch, Vincent Van, Horakova, Dana, Ampapa, Radek, Patti, Francesco, et al. (2023). A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry.
Spelman, Tim, Ozakbas, Serkan, Alroughani, Raed, Terzi, Murat, Hodgkinson, Suzanne, Laureys, Guy, Kalincik, Tomas, Der Walt, Anneke Van, Yamout, Bassem, Lechner-Scott, Jeannette, Soysal, Aysun, Neurodegenerative Disease Management, 13(4), 215–221. https://doi.org/10.2217/nmt-2023-0005
, Sanchez-Menoyo, Jose Luis, Morgado, Yolanda Blanco, Spitaleri, Daniele L.A., Pesch, Vincent Van, Horakova, Dana, Ampapa, Radek, Patti, Francesco, et al. (2023). A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry.
Kiss, Máté G., Mindur, John E., Yates, Abi G., Lee, Donghoon, Fullard, John F., Anzai, Atsushi, Poller, Wolfram C., Christie, Kathleen A., Iwamoto, Yoshiko, Roudko, Vladimir, Downey, Jeffrey, Chan, Christopher T., Huynh, Pacific, Janssen, Henrike, Ntranos, Achilles, Hoffmann, Jan D., Jacob, Walter, Goswami, Sukanya, Singh, Sumnima, et al. (2023). Interleukin-3 coordinates glial-peripheral immune crosstalk to incite multiple sclerosis. Immunity, 56(7), 1502–1514. https://doi.org/10.1016/j.immuni.2023.04.013
Kiss, Máté G., Mindur, John E., Yates, Abi G., Lee, Donghoon, Fullard, John F., Anzai, Atsushi, Poller, Wolfram C., Christie, Kathleen A., Iwamoto, Yoshiko, Roudko, Vladimir, Downey, Jeffrey, Chan, Christopher T., Huynh, Pacific, Janssen, Henrike, Ntranos, Achilles, Hoffmann, Jan D., Jacob, Walter, Goswami, Sukanya, Singh, Sumnima, et al. (2023). Interleukin-3 coordinates glial-peripheral immune crosstalk to incite multiple sclerosis. Immunity, 56(7), 1502–1514. https://doi.org/10.1016/j.immuni.2023.04.013
Kalincik, Tomas, Sharmin, Sifat, Roos, Izanne, Freedman, Mark S., Atkins, Harold, Burman, Joachim, Massey, Jennifer, Sutton, Ian, Withers, Barbara, MacDonell, Richard, Grigg, Andrew, Torkildsen, Øivind, Bo, Lars, Lehmann, Anne Kristine, Havrdova, Eva Kubala, Krasulova, Eva, Trněný, Marek, Kozak, Tomas, Van Der Walt, Anneke, et al. (2023). Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis. JAMA Neurology, 80(7), 702–713. https://doi.org/10.1001/jamaneurol.2023.1184
Kalincik, Tomas, Sharmin, Sifat, Roos, Izanne, Freedman, Mark S., Atkins, Harold, Burman, Joachim, Massey, Jennifer, Sutton, Ian, Withers, Barbara, MacDonell, Richard, Grigg, Andrew, Torkildsen, Øivind, Bo, Lars, Lehmann, Anne Kristine, Havrdova, Eva Kubala, Krasulova, Eva, Trněný, Marek, Kozak, Tomas, Van Der Walt, Anneke, et al. (2023). Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis. JAMA Neurology, 80(7), 702–713. https://doi.org/10.1001/jamaneurol.2023.1184
Zhu, Chao, Kalincik, Tomas, Horakova, Dana, Zhou, Zhen, Buzzard, Katherine, Skibina, Olga, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, JAMA Neurology, 80(7), 739–748. https://doi.org/10.1001/jamaneurol.2023.1542
, Patti, Francesco, Grand’maison, Francois, Hodgkinson, Suzanne, Grammond, Pierre, Lechner-Scott, Jeannette, Butler, Ernest, Prat, Alexandre, Girard, Marc, Duquette, Pierre, et al. (2023). Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation.
Zhu, Chao, Kalincik, Tomas, Horakova, Dana, Zhou, Zhen, Buzzard, Katherine, Skibina, Olga, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, JAMA Neurology, 80(7), 739–748. https://doi.org/10.1001/jamaneurol.2023.1542
, Patti, Francesco, Grand’maison, Francois, Hodgkinson, Suzanne, Grammond, Pierre, Lechner-Scott, Jeannette, Butler, Ernest, Prat, Alexandre, Girard, Marc, Duquette, Pierre, et al. (2023). Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation.
Bar-Or, Amit, Thanei, Gian-Andrea, Harp, Christopher, Bernasconi, Corrado, Bonati, Ulrike, Cross, Anne H., Fischer, Saloumeh, Gaetano, Laura, Hauser, Stephen L., Hendricks, Robert, Kappos, Ludwig, eBioMedicine, 93. https://doi.org/10.1016/j.ebiom.2023.104662
, Leppert, David, Model, Fabian, Sauter, Annette, Koendgen, Harold, Jia, Xiaoming, & Herman, Ann E. (2023). Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials.
Bar-Or, Amit, Thanei, Gian-Andrea, Harp, Christopher, Bernasconi, Corrado, Bonati, Ulrike, Cross, Anne H., Fischer, Saloumeh, Gaetano, Laura, Hauser, Stephen L., Hendricks, Robert, Kappos, Ludwig, eBioMedicine, 93. https://doi.org/10.1016/j.ebiom.2023.104662
, Leppert, David, Model, Fabian, Sauter, Annette, Koendgen, Harold, Jia, Xiaoming, & Herman, Ann E. (2023). Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials.
Bar-Or, Amit, Thanei, Gian-Andrea, Harp, Christopher, Bernasconi, Corrado, Bonati, Ulrike, Cross, Anne H., Fischer, Saloumeh, Gaetano, Laura, Hauser, Stephen L., Hendricks, Robert, Kappos, Ludwig, eBioMedicine, 93, 104662. https://doi.org/10.1016/j.ebiom.2023.104662
, Leppert, David, Model, Fabian, Sauter, Annette, Koendgen, Harold, Jia, Xiaoming, & Herman, Ann E. (2023). Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials [Journal-article].
Bar-Or, Amit, Thanei, Gian-Andrea, Harp, Christopher, Bernasconi, Corrado, Bonati, Ulrike, Cross, Anne H., Fischer, Saloumeh, Gaetano, Laura, Hauser, Stephen L., Hendricks, Robert, Kappos, Ludwig, eBioMedicine, 93, 104662. https://doi.org/10.1016/j.ebiom.2023.104662
, Leppert, David, Model, Fabian, Sauter, Annette, Koendgen, Harold, Jia, Xiaoming, & Herman, Ann E. (2023). Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials [Journal-article].
Bavato, Francesco, Kexel, Ann-Kathrin, Kluwe-Schiavon, Bruno, Maceski, Aleksandra, Baumgartner, Markus R., Seifritz, Erich, Molecular Neurobiology, 60(7), 3935–3944. https://doi.org/10.1007/s12035-023-03327-6
, & Quednow, Boris B. (2023). A Longitudinal Investigation of Blood Neurofilament Light Chain Levels in Chronic Cocaine Users.
Bavato, Francesco, Kexel, Ann-Kathrin, Kluwe-Schiavon, Bruno, Maceski, Aleksandra, Baumgartner, Markus R., Seifritz, Erich, Molecular Neurobiology, 60(7), 3935–3944. https://doi.org/10.1007/s12035-023-03327-6
, & Quednow, Boris B. (2023). A Longitudinal Investigation of Blood Neurofilament Light Chain Levels in Chronic Cocaine Users.
Brousse, Mehdi, Delaby, Constance, De La Cruz, Elisa, European Journal of Neurology, 30(7), 1919–1927. https://doi.org/10.1111/ene.15813
, Benkert, Pascal, Mondesert, Etienne, Ginestet, Nelly, Hirtz, Christophe, Camu, William, Lehmann, Sylvain, & Esselin, Florence. (2023). Serum neurofilament light chain cut-off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis.
Brousse, Mehdi, Delaby, Constance, De La Cruz, Elisa, European Journal of Neurology, 30(7), 1919–1927. https://doi.org/10.1111/ene.15813
, Benkert, Pascal, Mondesert, Etienne, Ginestet, Nelly, Hirtz, Christophe, Camu, William, Lehmann, Sylvain, & Esselin, Florence. (2023). Serum neurofilament light chain cut-off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis.
Geis, Tobias, Gutzeit, Svena, Fouzas, Sotiris, Ambrosch, Andreas, Benkert, Pascal, European Journal of Paediatric Neurology, 45, 9–13. https://doi.org/10.1016/j.ejpn.2023.05.003
, & Wellmann, Sven. (2023). Serum Neurofilament light chain (NfL) levels in children with and without neurologic diseases.
Geis, Tobias, Gutzeit, Svena, Fouzas, Sotiris, Ambrosch, Andreas, Benkert, Pascal, European Journal of Paediatric Neurology, 45, 9–13. https://doi.org/10.1016/j.ejpn.2023.05.003
, & Wellmann, Sven. (2023). Serum Neurofilament light chain (NfL) levels in children with and without neurologic diseases.
Telser, Julia, Grossmann, Kirsten, Weideli, Ornella C., Hillmann, Dorothea, Aeschbacher, Stefanie, Wohlwend, Niklas, Velez, Laura, Diagnostics, 13(13). https://doi.org/10.3390/diagnostics13132167
, Maleska, Aleksandra, Benkert, Pascal, Risch, Corina, Conen, David, Risch, Martin, & Risch, Lorenz. (2023). Concentrations of Serum Brain Injury Biomarkers Following SARS-CoV-2 Infection in Individuals with and without Long-COVID—Results from the Prospective Population-Based COVI-GAPP Study.
Telser, Julia, Grossmann, Kirsten, Weideli, Ornella C., Hillmann, Dorothea, Aeschbacher, Stefanie, Wohlwend, Niklas, Velez, Laura, Diagnostics, 13(13). https://doi.org/10.3390/diagnostics13132167
, Maleska, Aleksandra, Benkert, Pascal, Risch, Corina, Conen, David, Risch, Martin, & Risch, Lorenz. (2023). Concentrations of Serum Brain Injury Biomarkers Following SARS-CoV-2 Infection in Individuals with and without Long-COVID—Results from the Prospective Population-Based COVI-GAPP Study.
Abdelhak, Ahmed, JAMA Neurology, 80(6), 542–543. https://doi.org/10.1001/jamaneurol.2023.0394
, & Green, Ari J. (2023). Challenges and Opportunities for the Promising Biomarker Blood Neurofilament Light Chain.
Abdelhak, Ahmed, JAMA Neurology, 80(6), 542–543. https://doi.org/10.1001/jamaneurol.2023.0394
, & Green, Ari J. (2023). Challenges and Opportunities for the Promising Biomarker Blood Neurofilament Light Chain.
Andreasson U, Gobom J, Delatour V, Auclair G, Noam Y, Lee S, Wen J, Jeromin A, Arslan B, Maceski A, Willemse E, Zetterberg H, Clinical Chemistry and Laboratory Medicine, 61(7), 1245–1254. https://doi.org/10.1515/cclm-2022-1181
, & Blennow K. (2023). Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood.
Andreasson U, Gobom J, Delatour V, Auclair G, Noam Y, Lee S, Wen J, Jeromin A, Arslan B, Maceski A, Willemse E, Zetterberg H, Clinical Chemistry and Laboratory Medicine, 61(7), 1245–1254. https://doi.org/10.1515/cclm-2022-1181
, & Blennow K. (2023). Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood.
Daruwalla, Cyrus, Shaygannejad, Vahid, Ozakbas, Serkan, Havrdova, Eva Kubala, Horakova, Dana, Alroughani, Raed, Boz, Cavit, Patti, Francesco, Onofrj, Marco, Lugaresi, Alessandra, Eichau, Sara, Girard, Marc, Prat, Alexandre, Duquette, Pierre, Yamout, Bassem, Khoury, Samia J, Sajedi, Seyed Aidin, Turkoglu, Recai, Altintas, Ayse, et al. (2023). Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 29(7), 875–883. https://doi.org/10.1177/13524585231151951
Daruwalla, Cyrus, Shaygannejad, Vahid, Ozakbas, Serkan, Havrdova, Eva Kubala, Horakova, Dana, Alroughani, Raed, Boz, Cavit, Patti, Francesco, Onofrj, Marco, Lugaresi, Alessandra, Eichau, Sara, Girard, Marc, Prat, Alexandre, Duquette, Pierre, Yamout, Bassem, Khoury, Samia J, Sajedi, Seyed Aidin, Turkoglu, Recai, Altintas, Ayse, et al. (2023). Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 29(7), 875–883. https://doi.org/10.1177/13524585231151951
Ziaei, Amin, Nasr, Zahra, Hart, Janace, Francisco, Carla, Rutatangwa, Alice, Leppert, David, Multiple Sclerosis and Related Disorders, 74. https://doi.org/10.1016/j.msard.2023.104704
, Flanagan, Eoin, & Waubant, Emmanuelle. (2023). High serum neurofilament levels are observed close to disease activity events in pediatric-onset MS and MOG antibody-associated diseases.
Ziaei, Amin, Nasr, Zahra, Hart, Janace, Francisco, Carla, Rutatangwa, Alice, Leppert, David, Multiple Sclerosis and Related Disorders, 74. https://doi.org/10.1016/j.msard.2023.104704
, Flanagan, Eoin, & Waubant, Emmanuelle. (2023). High serum neurofilament levels are observed close to disease activity events in pediatric-onset MS and MOG antibody-associated diseases.
Buchmann, Arabella, Pirpamer, Lukas, Pinter, Daniela, Voortman, Margarete, Helmlinger, Birgit, Pichler, Alexander, Maceski, Aleksandra Maleska, Benkert, Pascal, Bachmaier, Gerhard, Ropele, Stefan, Reindl, Markus, Leppert, David, European Journal of Neurology, 30(5), 1389–1399. https://doi.org/10.1111/ene.15742
, Enzinger, Christian, & Khalil, Michael. (2023). High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis.
Buchmann, Arabella, Pirpamer, Lukas, Pinter, Daniela, Voortman, Margarete, Helmlinger, Birgit, Pichler, Alexander, Maceski, Aleksandra Maleska, Benkert, Pascal, Bachmaier, Gerhard, Ropele, Stefan, Reindl, Markus, Leppert, David, European Journal of Neurology, 30(5), 1389–1399. https://doi.org/10.1111/ene.15742
, Enzinger, Christian, & Khalil, Michael. (2023). High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis.
Tsagkas, Charidimos, Huck-Horvath, Antal, Cagol, Alessandro, Haas, Tanja, Barakovic, Muhamed, Amann, Michael, Ruberte, Esther, Melie-Garcia, Lester, Weigel, Matthias, Pezold, Simon, Schlaeger, Regina, Multiple Sclerosis Journal, 29(6), 702–718. https://doi.org/10.1177/13524585221139152
, Sprenger, Till, Kappos, Ludwig, Bieri, Oliver, Cattin, Philippe, Granziera, Cristina, & Parmar, Katrin. (2023). Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis.
Tsagkas, Charidimos, Huck-Horvath, Antal, Cagol, Alessandro, Haas, Tanja, Barakovic, Muhamed, Amann, Michael, Ruberte, Esther, Melie-Garcia, Lester, Weigel, Matthias, Pezold, Simon, Schlaeger, Regina, Multiple Sclerosis Journal, 29(6), 702–718. https://doi.org/10.1177/13524585221139152
, Sprenger, Till, Kappos, Ludwig, Bieri, Oliver, Cattin, Philippe, Granziera, Cristina, & Parmar, Katrin. (2023). Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis.
Tsagkas, Charidimos, Huck-Horvath, Antal, Cagol, Alessandro, Haas, Tanja, Barakovic, Muhamed, Amann, Michael, Ruberte, Esther, Melie-Garcia, Lester, Weigel, Matthias, Pezold, Simon, Schlaeger, Regina, Multiple Sclerosis Journal, 29(6), 702–718. https://doi.org/10.1177/13524585221139152
, Sprenger, Till, Kappos, Ludwig, Bieri, Oliver, Cattin, Philippe, Granziera, Cristina, & Parmar, Katrin. (2023). Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis [Journal-article].
Tsagkas, Charidimos, Huck-Horvath, Antal, Cagol, Alessandro, Haas, Tanja, Barakovic, Muhamed, Amann, Michael, Ruberte, Esther, Melie-Garcia, Lester, Weigel, Matthias, Pezold, Simon, Schlaeger, Regina, Multiple Sclerosis Journal, 29(6), 702–718. https://doi.org/10.1177/13524585221139152
, Sprenger, Till, Kappos, Ludwig, Bieri, Oliver, Cattin, Philippe, Granziera, Cristina, & Parmar, Katrin. (2023). Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis [Journal-article].
Cagol A, Fuertes NC, Stoessel M, Barakovic M, Schaedelin S, D’Souza M, Würfel J, Brandt AU, Kappos L, Sprenger T, Naegelin Y, Journal of Neurology, 270(4), 2139–2148. https://doi.org/10.1007/s00415-022-11535-8
, Granziera C, & Papadopoulou A. (2023). Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis.
Cagol A, Fuertes NC, Stoessel M, Barakovic M, Schaedelin S, D’Souza M, Würfel J, Brandt AU, Kappos L, Sprenger T, Naegelin Y, Journal of Neurology, 270(4), 2139–2148. https://doi.org/10.1007/s00415-022-11535-8
, Granziera C, & Papadopoulou A. (2023). Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis.
Margraf NG, Dargvainiene J, Theel E, Leypoldt F, Lieb W, Franke A, Berger K, Journal of Neurology, 270(4), 2128–2138. https://doi.org/10.1007/s00415-022-11547-4
, & Kuhlenbaeumer G. (2023). Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus.
Margraf NG, Dargvainiene J, Theel E, Leypoldt F, Lieb W, Franke A, Berger K, Journal of Neurology, 270(4), 2128–2138. https://doi.org/10.1007/s00415-022-11547-4
, & Kuhlenbaeumer G. (2023). Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus.
Nittas, Vasileios, Zecca, Chiara, Kamm, Christian P., PLoS ONE, 18(4 APRIL). https://doi.org/10.1371/journal.pone.0284477
, Chan, Andrew, & Wyl, Viktor Von. (2023). Digital health for chronic disease management: An exploratory method to investigating technology adoption potential.
Nittas, Vasileios, Zecca, Chiara, Kamm, Christian P., PLoS ONE, 18(4 APRIL). https://doi.org/10.1371/journal.pone.0284477
, Chan, Andrew, & Wyl, Viktor Von. (2023). Digital health for chronic disease management: An exploratory method to investigating technology adoption potential.
Theil, Diethilde, Toxicologic Pathology, 51(3), 135–147. https://doi.org/10.1177/01926233231180179
, Brees, Dominique, Tritto, Elaine, Pognan, François, Frieauff, Wilfried, Penraat, Kelley, Meseck, Emily, Valdez, Reginald, & Hartmann, Andreas. (2023). Neurofilament Light Chain: A Translational Safety Biomarker for Drug-Induced Peripheral Neurotoxicity.
Theil, Diethilde, Toxicologic Pathology, 51(3), 135–147. https://doi.org/10.1177/01926233231180179
, Brees, Dominique, Tritto, Elaine, Pognan, François, Frieauff, Wilfried, Penraat, Kelley, Meseck, Emily, Valdez, Reginald, & Hartmann, Andreas. (2023). Neurofilament Light Chain: A Translational Safety Biomarker for Drug-Induced Peripheral Neurotoxicity.
Vermunt, L., Sutphen, C., Dicks, E., de Leeuw, D. M., Allegri, R., Berman, S. B., Cash, D. M., Chhatwal, J. P., Cruchaga, C., Day, G., Ewers, M., Farlow, M., Fox, N. C., Ghetti, B., Graff-Radford, N., Hassenstab, J., Jucker, M., Karch, C. M., Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.03.21.23287468
, et al. (2023).
Vermunt, L., Sutphen, C., Dicks, E., de Leeuw, D. M., Allegri, R., Berman, S. B., Cash, D. M., Chhatwal, J. P., Cruchaga, C., Day, G., Ewers, M., Farlow, M., Fox, N. C., Ghetti, B., Graff-Radford, N., Hassenstab, J., Jucker, M., Karch, C. M., Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.03.21.23287468
, et al. (2023).
Meier, Stephanie, Willemse, Eline A.J., Schaedelin, Sabine, Oechtering, Johanna, Lorscheider, Johannes, Melie-Garcia, Lester, Cagol, Alessandro, Barakovic, Muhamed, Galbusera, Riccardo, Subramaniam, Suvitha, Barro, Christian, Abdelhak, Ahmed, Thebault, Simon, Achtnichts, Lutz, Lalive, Patrice, Müller, Stefanie, Pot, Caroline, Salmen, Anke, Disanto, Giulio, et al. (2023). Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis. JAMA Neurology, 80(3), 287–297. https://doi.org/10.1001/jamaneurol.2022.5250
Meier, Stephanie, Willemse, Eline A.J., Schaedelin, Sabine, Oechtering, Johanna, Lorscheider, Johannes, Melie-Garcia, Lester, Cagol, Alessandro, Barakovic, Muhamed, Galbusera, Riccardo, Subramaniam, Suvitha, Barro, Christian, Abdelhak, Ahmed, Thebault, Simon, Achtnichts, Lutz, Lalive, Patrice, Müller, Stefanie, Pot, Caroline, Salmen, Anke, Disanto, Giulio, et al. (2023). Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis. JAMA Neurology, 80(3), 287–297. https://doi.org/10.1001/jamaneurol.2022.5250
Hamza, Tasnim, Chalkou, Konstantina, Pellegrini, Fabio, Research Synthesis Methods, 14(2), 283–300. https://doi.org/10.1002/jrsm.1619
, Benkert, Pascal, Lorscheider, Johannes, Zecca, Chiara, Iglesias-Urrutia, Cynthia P., Manca, Andrea, Furukawa, Toshi A., Cipriani, Andrea, & Salanti, Georgia. (2023). Synthesizing cross-design evidence and cross-format data using network meta-regression.
Hamza, Tasnim, Chalkou, Konstantina, Pellegrini, Fabio, Research Synthesis Methods, 14(2), 283–300. https://doi.org/10.1002/jrsm.1619
, Benkert, Pascal, Lorscheider, Johannes, Zecca, Chiara, Iglesias-Urrutia, Cynthia P., Manca, Andrea, Furukawa, Toshi A., Cipriani, Andrea, & Salanti, Georgia. (2023). Synthesizing cross-design evidence and cross-format data using network meta-regression.
Multiple Sclerosis Journal, 29(3), 385–394. https://doi.org/10.1177/13524585221144742
, Chitnis T., Banwell B., Tardieu M., Arnold DL, Rawlings A.M., Geertsen S.S., Lublin AL, Saubadu S., Truffinet P., & Kappos L. (2023). Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial.
Multiple Sclerosis Journal, 29(3), 385–394. https://doi.org/10.1177/13524585221144742
, Chitnis T., Banwell B., Tardieu M., Arnold DL, Rawlings A.M., Geertsen S.S., Lublin AL, Saubadu S., Truffinet P., & Kappos L. (2023). Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial.
Loser, Valentin, Benkert, Pascal, Vicino, Alex, Lim Dubois Ferriere, Pansy, Kuntzer, Thierry, Pasquier, Jérôme, Maceski, Aleksandra, Kuhle, Jens, & Journal of the Peripheral Nervous System, 28(1), 86–97. https://doi.org/10.1111/jns.12524
. (2023). Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin-related amyloidosis—A Swiss reference center experience.
Loser, Valentin, Benkert, Pascal, Vicino, Alex, Lim Dubois Ferriere, Pansy, Kuntzer, Thierry, Pasquier, Jérôme, Maceski, Aleksandra, Kuhle, Jens, & Journal of the Peripheral Nervous System, 28(1), 86–97. https://doi.org/10.1111/jns.12524
. (2023). Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin-related amyloidosis—A Swiss reference center experience.
Montalban X, Matthews PM, Simpson A, Petrie JL, Sammon C, Ramagopalan S, Disanto G, & Annals of Clinical and Translational Neurology, 10(3), 302–311. https://doi.org/10.1002/acn3.51732
. (2023). Real-world evaluation of ocrelizumab in multiple sclerosis: A systematic review.
Montalban X, Matthews PM, Simpson A, Petrie JL, Sammon C, Ramagopalan S, Disanto G, & Annals of Clinical and Translational Neurology, 10(3), 302–311. https://doi.org/10.1002/acn3.51732
. (2023). Real-world evaluation of ocrelizumab in multiple sclerosis: A systematic review.
Tsagkas, Charidimos, Huck-Horvath, Antal, Cagol, Alessandro, Haas, Tanja, Amann, Michael, Barakovic, Muhamed, Ruberte, Esther, Melie-Garcia, Lester, Weigel, Matthias, Pezold, Simon, Schlaeger, Regina, Multiple Sclerosis and Related Disorders, 71, 104545. https://doi.org/10.1016/j.msard.2023.104545
, Sprenger, Till, Kappos, Ludwig, Bieri, Oliver, Cattin, Philippe, Granziera, Cristina, & Parmar, Katrin. (2023). Longitudinal assessment of cervical spinal cord compartments in multiple sclerosis [Journal-article].
Tsagkas, Charidimos, Huck-Horvath, Antal, Cagol, Alessandro, Haas, Tanja, Amann, Michael, Barakovic, Muhamed, Ruberte, Esther, Melie-Garcia, Lester, Weigel, Matthias, Pezold, Simon, Schlaeger, Regina, Multiple Sclerosis and Related Disorders, 71, 104545. https://doi.org/10.1016/j.msard.2023.104545
, Sprenger, Till, Kappos, Ludwig, Bieri, Oliver, Cattin, Philippe, Granziera, Cristina, & Parmar, Katrin. (2023). Longitudinal assessment of cervical spinal cord compartments in multiple sclerosis [Journal-article].
Tsagkas C, Huck-Horvath A, Cagol A, Haas T, Amann M, Barakovic M, Ruberte E, Melie-Garcia L, Weigel M, Pezold S, Schlaeger R, Multiple Sclerosis and Related Disorders, 71, 104545. https://doi.org/10.1016/j.msard.2023.104545
, Sprenger T, Kappos L, Bieri O, Cattin P, Granziera C, & Parmar K. (2023). Longitudinal assessment of cervical spinal cord compartments in multiple sclerosis.
Tsagkas C, Huck-Horvath A, Cagol A, Haas T, Amann M, Barakovic M, Ruberte E, Melie-Garcia L, Weigel M, Pezold S, Schlaeger R, Multiple Sclerosis and Related Disorders, 71, 104545. https://doi.org/10.1016/j.msard.2023.104545
, Sprenger T, Kappos L, Bieri O, Cattin P, Granziera C, & Parmar K. (2023). Longitudinal assessment of cervical spinal cord compartments in multiple sclerosis.
Telser, J., Grossmann, K., Weideli, O. C., Hillmann, D., Aeschbacher, S., Wohlwend, N., Velez, L., Kuhle, J., Maleska, A., Benkert, P., Risch, C., Conen, D., Risch, M., & Risch, L. (2023, February 16). The role of serum brain injury biomarkers in individuals with a mild-to-moderate COVID infection and Long-COVID - results from the prospective population-based COVI-GAPP study [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.02.15.23285972
Telser, J., Grossmann, K., Weideli, O. C., Hillmann, D., Aeschbacher, S., Wohlwend, N., Velez, L., Kuhle, J., Maleska, A., Benkert, P., Risch, C., Conen, D., Risch, M., & Risch, L. (2023, February 16). The role of serum brain injury biomarkers in individuals with a mild-to-moderate COVID infection and Long-COVID - results from the prospective population-based COVI-GAPP study [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.02.15.23285972
Wenger A.L., Barakovic, Muhamed, Bosticardo, Sara, Schaedelin, Sabine, Daducci, Alessandro, Schiavi, Simona, Weigel, Matthias, Rahmanzadeh, Reza, Lu, Po-Jui, Cagol, Alessandro, Kappos, Ludwig, Frontiers in Neuroscience, 17. https://doi.org/10.3389/fnins.2023.1007580
, Calabrese, Pasquale, & Granziera, Cristina. (2023). An investigation of the association between focal damage and global network properties in cognitively impaired and cognitively preserved patients with multiple sclerosis.
Wenger A.L., Barakovic, Muhamed, Bosticardo, Sara, Schaedelin, Sabine, Daducci, Alessandro, Schiavi, Simona, Weigel, Matthias, Rahmanzadeh, Reza, Lu, Po-Jui, Cagol, Alessandro, Kappos, Ludwig, Frontiers in Neuroscience, 17. https://doi.org/10.3389/fnins.2023.1007580
, Calabrese, Pasquale, & Granziera, Cristina. (2023). An investigation of the association between focal damage and global network properties in cognitively impaired and cognitively preserved patients with multiple sclerosis.